financetom
Business
financetom
/
Business
/
ScPharmaceuticals Receives 5 Patent Allowances for Furosemide Formulation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ScPharmaceuticals Receives 5 Patent Allowances for Furosemide Formulation
Aug 14, 2025 6:38 AM

09:18 AM EDT, 08/14/2025 (MT Newswires) -- ScPharmaceuticals ( SCPH ) said Thursday it received five notices of allowance from the US Patent and Trademark Office for patent applications covering its SCP-111 furosemide formulation.

A notice of allowance informs the applicant that the patent or trademark application has been approved and is ready for the next steps towards registration, according to the USPTO.

ScPharmaceuticals ( SCPH ) said the patents, once granted, will add to the four existing patents related to SCP-111.

The company said it plans to file a supplemental new drug application for the formulation in the current quarter.

ScPharmaceuticals ( SCPH ) shares were up 2.9% in recent premarket activity Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Alpha Group International plc
Form 8.3 - Alpha Group International plc
Sep 10, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...
Form 8.3 - Just Group plc
Form 8.3 - Just Group plc
Sep 10, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...
Terreno Realty Corporation Acquires Portfolio in Doral, FL and Kearny, NJ for $194.3 Million
Terreno Realty Corporation Acquires Portfolio in Doral, FL and Kearny, NJ for $194.3 Million
Sep 10, 2025
- Completes $426.9 Million Multi-Market Portfolio Acquisition BELLEVUE, Wash.--(BUSINESS WIRE)-- Terreno Realty Corporation ( TRNO ) , an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, acquired industrial properties located in Doral, Florida and Kearny, New Jersey on September 9, 2025 for a purchase price of approximately $194.3 million. The portfolio consists of...
Microchip Technology Unit, Deca to Develop NVM Chiplet Package
Microchip Technology Unit, Deca to Develop NVM Chiplet Package
Sep 10, 2025
09:11 AM EDT, 09/10/2025 (MT Newswires) -- Microchip Technology ( MCHP ) said Wednesday its Silicon Storage Technology unit is collaborating with Deca Technologies to develop non-volatile memory chiplet packages for the adoption of modular multi-die systems. Under the deal, both companies will integrate technologies to develop a bundled offering that allows customers to design, verify and commercialize NVM chiplets....
Copyright 2023-2026 - www.financetom.com All Rights Reserved